Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 4
1994 1
1995 5
1996 16
1997 18
1998 43
1999 75
2000 101
2001 98
2002 155
2003 170
2004 246
2005 260
2006 293
2007 334
2008 295
2009 289
2010 305
2011 324
2012 339
2013 354
2014 298
2015 346
2016 325
2017 303
2018 305
2019 254
2020 295
2021 286
Text availability
Article attribute
Article type
Publication date

Search Results

5,543 results
Results by year
Filters applied: . Clear all
Page 1
Quetiapine.
Maan JS, Ershadi M, Khan I, Saadabadi A. Maan JS, et al. 2021 Sep 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. 2021 Sep 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29083706 Free Books & Documents. Review.
Quetiapine is FDA approved for schizophrenia, acute manic episodes, and adjunctive treatment for major depressive disorder. Quetiapine is also used for several non-FDA-approved indications, such as generalized anxiety disorder. ...
Quetiapine is FDA approved for schizophrenia, acute manic episodes, and adjunctive treatment for major depressive disorder. Quetia
Quetiapine for insomnia: A review of the literature.
Anderson SL, Vande Griend JP. Anderson SL, et al. Am J Health Syst Pharm. 2014 Mar 1;71(5):394-402. doi: 10.2146/ajhp130221. Am J Health Syst Pharm. 2014. PMID: 24534594 Review.
No trials have been conducted comparing quetiapine with an active control (e.g., zolpidem); the data that exist compare quetiapine to a placebo or there is no comparison and all patients are treated with quetiapine. Very few studies have evaluated quetiapi
No trials have been conducted comparing quetiapine with an active control (e.g., zolpidem); the data that exist compare quetiapine
Quetiapine safety in older adults: a systematic literature review.
El-Saifi N, Moyle W, Jones C, Tuffaha H. El-Saifi N, et al. J Clin Pharm Ther. 2016 Feb;41(1):7-18. doi: 10.1111/jcpt.12357. J Clin Pharm Ther. 2016. PMID: 26813985 Review.
WHAT IS KNOWN AND OBJECTIVE: Quetiapine is a second-generation antipsychotic that is commonly prescribed for a range of approved and off-label indications in older adults. ...There are no systematic reviews on the safety of quetiapine in older adults, and therefore, …
WHAT IS KNOWN AND OBJECTIVE: Quetiapine is a second-generation antipsychotic that is commonly prescribed for a range of approved and …
Quetiapine is not a sleeping pill.
Debernard KAB, Frost J, Roland PH. Debernard KAB, et al. Tidsskr Nor Laegeforen. 2019 Sep 16;139(13). doi: 10.4045/tidsskr.19.0205. Print 2019 Sep 24. Tidsskr Nor Laegeforen. 2019. PMID: 31556541 Free article. English, Norwegian.
Use of the antipsychotic drug quetiapine to treat sleep disorders has become widespread, also in Norway. Its efficacy is poorly documented, and even low doses may have substantial side effects. There is thus reason to warn against prescribing quetiapine for sleep... …
Use of the antipsychotic drug quetiapine to treat sleep disorders has become widespread, also in Norway. Its efficacy is poorly docum …
Quetiapine for acute bipolar depression: a systematic review and meta-analysis.
Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Suttajit S, et al. Drug Des Devel Ther. 2014 Jun 25;8:827-38. doi: 10.2147/DDDT.S63779. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25028535 Free PMC article. Review.
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. ...CONCLUSION: Quetiapine monotherapy is effective for acute bipolar depression and the prevention of mania/hypomania switching. ...
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. ...CONC …
Quetiapine.
[No authors listed] [No authors listed] 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000146 Free Books & Documents. Review.
Maternal quetiapine doses of up to 400 mg daily produce low levels in milk. Limited long-term follow-up of infants exposed to quetiapine indicates that infants generally developed normally. A safety scoring system finds quetiapine to be possible to use during …
Maternal quetiapine doses of up to 400 mg daily produce low levels in milk. Limited long-term follow-up of infants exposed to quet
Quetiapine Poisoning and Factors Influencing Severity.
Peridy E, Hamel JF, Rolland AL, Gohier B, Boels D. Peridy E, et al. J Clin Psychopharmacol. 2019 Jul/Aug;39(4):312-317. doi: 10.1097/JCP.0000000000001053. J Clin Psychopharmacol. 2019. PMID: 31205192
PURPOSE/BACKGROUND: Quetiapine is a relatively new atypical antipsychotic with fewer adverse effects. ...CONCLUSIONS: Quetiapine may lead to severe poisoning for which there is currently no specific treatment. ...
PURPOSE/BACKGROUND: Quetiapine is a relatively new atypical antipsychotic with fewer adverse effects. ...CONCLUSIONS: Quetiapine
[Quetiapine].
Kusumi I. Kusumi I. Nihon Rinsho. 2013 Apr;71(4):673-7. Nihon Rinsho. 2013. PMID: 23678598 Review. Japanese.
Quetiapine is a unique antipsychotic drug characterized by the weakest affinity for dopamine D2 receptors of all the antipsychotics. ...Plenty dose of quetiapine is effective for schizophrenia patients suffered from severe insomnia, catatonia, emotional instability,
Quetiapine is a unique antipsychotic drug characterized by the weakest affinity for dopamine D2 receptors of all the antipsychotics.
Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E. Devlin JW, et al. Crit Care Med. 2010 Feb;38(2):419-27. doi: 10.1097/CCM.0b013e3181b9e302. Crit Care Med. 2010. PMID: 19915454 Clinical Trial.
Whereas mortality (11% quetiapine vs. 17%) and intensive care unit length of stay (16 quetiapine vs. 16 days) were similar, subjects treated with quetiapine were more likely to be discharged home or to rehabilitation (89% quetiapine vs. 56%; p =.06). S …
Whereas mortality (11% quetiapine vs. 17%) and intensive care unit length of stay (16 quetiapine vs. 16 days) were similar, su …
[Quetiapine for the people?].
Gjerden P, Slørdal L. Gjerden P, et al. Tidsskr Nor Laegeforen. 2020 Sep 28;140(13). doi: 10.4045/tidsskr.20.0704. Print 2020 Sep 29. Tidsskr Nor Laegeforen. 2020. PMID: 32998495 Free article. Norwegian. No abstract available.
5,543 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page